(RTTNews) - Oil prices jumped more than 3 percent on Monday in the wake of renewed concerns about energy supply as U.S. President Donald Trump rejected Iran's latest proposal to reopen the Strait of Hormuz and signaled possible new military strikes after midterm elections.
(RTTNews) - Adicet Bio, Inc. (ACET) shares in the pre-market are active ahead of the company's planned release of Phase 1 clinical data for prulacabtagene leucel (prula-cel) in systemic lupus erythematosus (SLE), with or without lupus nephritis (LN).
(RTTNews) - Nanjing Leads Biolabs Co., Ltd. (9887.HK) on Monday announced that Opamtistomig (LBL-024), the company's investigational PD-L1/4-1BB bispecific antibody, has been granted Orphan Drug Designation (ODD) by Japan's Ministry of Health, Labour and Welfare (MHLW) for the tr
Key PointsIt’s been a year of unrivaled change for Berkshire Hathaway’s shareholders, with Warren Buffett retiring as CEO and stepping down as chairman of the board.
(RTTNews) - European stocks were modestly higher on Monday despite concerns over rising oil prices and elevated bond yields after U.S. President Donald Trump rejected an Iranian proposal to reopen the Strait of Hormuz and end the war.
(RTTNews) - Nanexa AB, a Swedish drug delivery platform company developing long-acting injectable drugs, announced that it has entered into a global exclusive license and collaboration agreement with Novo Nordisk A/S (NVO) for the use of it's PharmaShell technology platform for c
(RTTNews) - Hugo Boss AG (BOSSY, BOSS.DE, BOSS.F), a fashion and lifestyle company, on Monday announced that Yves Müller has stepped down from the Managing Board as Chief Financial Officer and Chief Operating Officer for personal reasons.
(RTTNews) - Daiichi Sankyo (4568.TS) and Merck (MRK) on Friday announced that they have voluntarily withdrawn the Biologics License Application (BLA) for Ifinatamab deruxtecan (I-DXd) for adult patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease had progr
(RTTNews) - Addex Therapeutics Ltd. (ADXN, ADXN.SW) on Monday reported a wider net loss for the first half, while operating loss narrowed from last year on lower research and development expenses.
(RTTNews) - Asian stocks ended mixed on Monday as Middle East tensions persisted, hawkish signals from Federal Reserve policymakers bolstered the case for another Fed rate hike this year, and new data showed China's industrial profit growth slowed further in August.
Oil prices
(RTTNews) - Addex Therapeutics Ltd (ADXN), a clinical-stage pharmaceutical company, released its second-quarter 2026 financial results on Monday and provided corporate updates for the quarter.
Key PointsAlthough the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite have soared under President Trump, it’s becoming increasingly difficult to sweep energy inflation under the rug.
(RTTNews) - Clinical-stage biotechnology company OSE Immunotherapeutics (OSE) reported a cash position of €11.1 million as of June 30, 2026, while highlighting progress across its oncology and immunology pipeline and reaffirming funding expected to support operations through Dece